Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Oncotarget|May 3, 2017
Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinomaWan Huang, Weiping Zhou, Can Li, et al.
Signal Transduction and Targeted Therapy|February 16, 2021
UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma developmentRen-Yu Zhang, Ze-Kun Liu, Ding Wei, et al.
Circulation Research|January 3, 2024
CD147 Sparks Atherosclerosis by Driving M1 Phenotype and Impairing EfferocytosisJian-Jun Lv, Hao Wang, Cong Zhang, et al.
Clinical and Molecular Hepatology|June 25, 2024
UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHLRenyu Zhang, Can Li, Shuai Zhang, et al.
Medcomm|March 24, 2025
Integrated Analysis of the Anoikis-Related Signature Identifies Rac Family Small GTPase 3 as a Novel Tumor-Promoter Gene in Hepatocellular CarcinomaDong Wu, Ze-Kun Liu, Ying Sun, et al.
Cancer Communications (London, England)|July 5, 2023
HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress-driven hepatocellular carcinoma progressionLin He, Hao Li, Can Li, et al.
Cell Reports|November 27, 2024
Nucleo-cytosolic acetyl-CoA drives tumor immune evasion by regulating PD-L1 in melanomaHuina Wang, Xiuli Yi, Xiangxu Wang, et al.
Cell Metabolism|January 6, 2021
Di-methylation of CD147-K234 Promotes the Progression of NSCLC by Enhancing Lactate ExportKe Wang, Wan Huang, Ruo Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 14, 2024
CD147-K148me2-Driven Tumor Cell-Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 AxisKe Wang, Xiaohong Chen, Peng Lin, et al.
Molecular Cancer|May 28, 2021
EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signalingZe-Kun Liu, Can Li, Ren-Yu Zhang, et al.
Pageof 10